首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.
【24h】

QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.

机译:使用支持向量机对Akt /蛋白激酶B(PKB)抑制剂进行QSAR研究。

获取原文
获取原文并翻译 | 示例
           

摘要

A three-class support vector classification (SVC) model with high prediction accuracy for the training, test and overall data sets (95.2%, 88.6% and 93.1%, respectively) was developed based on the molecular descriptors of 148 Akt/protein kinase B (PKB) inhibitors. Then, support vector regression (SVR) method was applied to set up a more accurate model with good correlation coefficient (r(2)) for the training, test and overall data sets (0.882, 0.762 and 0.840, respectively). Enrichment factors (EF) and receiver operating curves (ROC) studies of database screening were also performed either using the SVR model alone or assisted with the SVC model, the results of which demonstrated that the established models could be useful and reliable tools in identifying structurally diverse compounds with Akt inhibitory activity.
机译:基于148 Akt /蛋白激酶B的分子描述符,开发了具有三类支持向量分类(SVC)模型,该模型具有较高的预测准确性,可用于训练,测试和整体数据集(分别为95.2%,88.6%和93.1%) (PKB)抑制剂。然后,将支持向量回归(SVR)方法应用于训练,测试和总体数据集(分别为0.882、0.762和0.840)的具有良好相关系数(r(2))的更准确模型。还单独使用SVR模型或在SVC模型的辅助下进行了数据库筛选的富集因子(EF)和接收者操作曲线(ROC)研究,研究结果表明,所建立的模型对于结构上的识别可能是有用且可靠的工具具有Akt抑制活性的各种化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号